Global Precision Medicine Market Report 2022: Featuring Eli Lilly, AstraZeneca, Bristol-Myers Squibb, Intomics, Pfizer, Novartis & More
Global Precision Medicine Market
Dublin, Nov. 03, 2022 (GLOBE NEWSWIRE) -- The "Global Precision Medicine Market by Technology, Application, and Region - Size, Share, Outlook, and Opportunity Analysis 2019-2027" report has been added to ResearchAndMarkets.com's offering.
Precision medicine guides disease diagnosis, treatment, and prevention of cancer, hereditary diseases, and other disorders based on an individual's unique clinical, molecular, and lifestyle information. Doctors and researchers will be able to predict more accurately which treatment and prevention methods for a specific disease will work in which groups of people using this approach.
Through the use of pharmacogenomics, which analyses patient data to guide effective and safe medication plans for patients, precision medicine has the potential to enhance population health and lower overall healthcare costs. The detailed characterization of human biology is now possible owing to innovations in biomarkers, bioimaging, and wearable technologies. Clinicians employ a combination of genomic data, health records, lab tests, and other patient data to help personalise therapy in precision medicine. In this way they will be able to offer the appropriate treatment to the appropriate patient at the appropriate time.
Market Dynamics
The increasing adoption of inorganic strategies such as collaborations and partnerships by the key players in the market is expected to drive the global precision medicine market over the forecast period.
For instance, in September 2020, Thermo Fisher Scientific Inc., the world leader in serving science, announced new collaborations of the Thermo Fisher Precision Medicine Science Center (PMSC) with AstraZeneca, a multinational pharmaceutical and Biotechnology Company, and the University of Nebraska Medical Center, a public medical school in Omaha, Nebraska. The new collaboration will help strengthen the PMSC's mission of creating standardized workflows with pharma and academic partners to create new opportunities for precision medicine.
Detailed Segmentation
Global Precision Medicine Market, By Technology:
Bioinformatics
Gene Sequencing
Drug Discovery
Precision Molecular Diagnostics
Big Data Analytics
Global Precision Medicine Market, By Application:
Oncology
Breast Cancer
Lung Cancer
Others
Central Nervous System
Hematology
Respiratory
Immunology
Others
Global Precision Medicine Market, By Region:
North America
By Country
U.S.
Canada
Latin America
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Country
GCC
Israel
Rest of Middle East
Africa
By Region/Country
South Africa
Central Africa
North Africa
Company Profiles
Intomics
GENinCode
NanoString
Tepnel Pharma Services Limited
Pfizer Inc.
Novartis AG
Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc
QIAGEN
Quest Diagnostics Incorporated
Medtronic
Thermo Fisher Scientific Inc.
Laboratory Corporation of America Holdings
bioMerieux SA
Hoffmann-La Roche Ltd
Eli Lilly & Company
GlaxoSmithKline plc
Cepheid
AstraZeneca PLC
Myriad Genetics, Inc.
Bristol-Myers Squibb Company
Foundation Medicine, Inc.
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Precision Medicine Market- COVID-19 Impact Analysis
5. Global Precision Medicine Market, By Technology, 2017 - 2030, (US$ Million)
6. Global Precision Medicine Market, By Application, 2017 - 2030, (US$ Million)
7. Global Precision Medicine Market, By Region, 2017 - 2030, (US$ Million)
8. Competitive Landscape
9. Section
For more information about this report visit https://www.researchandmarkets.com/r/izqcyd
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900